These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

858 related items for PubMed ID: 20628295

  • 1. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review.
    Alzaga Fernandez AG, Demirci H, Darnley-Fisch DA, Steen DW.
    Cornea; 2010 Oct; 29(10):1189-91. PubMed ID: 20628295
    [Abstract] [Full Text] [Related]

  • 2. Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.
    Meskin SW, Carlson EM.
    Ocul Immunol Inflamm; 2011 Oct; 19(5):340-2. PubMed ID: 21823931
    [Abstract] [Full Text] [Related]

  • 3. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V, Mrowietz U.
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [Abstract] [Full Text] [Related]

  • 4. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
    Arenbergerova M, Gkalpakiotis S, Arenberger P.
    Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
    [Abstract] [Full Text] [Related]

  • 5. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R, Martínez-Taboada VM, Villa I, González-Vela MC, Fernández-Llaca H, Agudo M, González-López MA.
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [Abstract] [Full Text] [Related]

  • 6. Perforation in interstitial keratitis associated with hidradenitis suppurativa: medical and surgical management.
    Quigley C, Butler T, Murphy C, Power W.
    BMJ Case Rep; 2023 Jan 27; 16(1):. PubMed ID: 36707098
    [Abstract] [Full Text] [Related]

  • 7. The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.
    Moul DK, Korman NJ.
    Arch Dermatol; 2006 Sep 27; 142(9):1110-2. PubMed ID: 16982997
    [No Abstract] [Full Text] [Related]

  • 8. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
    van Rappard DC, Leenarts MF, Meijerink-van 't Oost L, Mekkes JR.
    J Dermatolog Treat; 2012 Aug 27; 23(4):284-9. PubMed ID: 21756155
    [Abstract] [Full Text] [Related]

  • 9. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D.
    Ann Pharmacother; 2009 Jun 27; 43(6):1139-42. PubMed ID: 19435962
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL, Singh MN, Chalmers RJ.
    Dermatol Online J; 2010 Aug 15; 16(8):15. PubMed ID: 20804692
    [Abstract] [Full Text] [Related]

  • 11. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
    Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB.
    Br J Dermatol; 2011 Aug 15; 165(2):391-8. PubMed ID: 21457202
    [Abstract] [Full Text] [Related]

  • 12. Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up.
    Odorcic S, Keystone EC, Ma JJ.
    Cornea; 2009 Jan 15; 28(1):89-92. PubMed ID: 19092414
    [Abstract] [Full Text] [Related]

  • 13. A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa.
    Amano M, Grant A, Kerdel FA.
    Int J Dermatol; 2010 Aug 15; 49(8):950-5. PubMed ID: 21128923
    [Abstract] [Full Text] [Related]

  • 14. Lyme disease associated with unilateral interstitial keratitis.
    Miyashiro MJ, Yee RW, Patel G, Ruiz RS.
    Cornea; 1999 Jan 15; 18(1):115-6. PubMed ID: 9894947
    [Abstract] [Full Text] [Related]

  • 15. Peripheral interstitial keratitis: a novel manifestation of ocular mastocytosis.
    Magone MT, Maric I, Hwang DG.
    Cornea; 2006 Apr 15; 25(3):364-7. PubMed ID: 16633043
    [Abstract] [Full Text] [Related]

  • 16. Interstitial keratitis presenting as the ocular manifestation of undiagnosed hidradenitis suppurativa.
    Lyle K, Zimmer JL, Gillette WM, Recko MS.
    Proc (Bayl Univ Med Cent); 2024 Apr 15; 37(3):479-481. PubMed ID: 38628332
    [Abstract] [Full Text] [Related]

  • 17. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
    Moschella SL.
    Int J Dermatol; 2007 Dec 15; 46(12):1287-91. PubMed ID: 18173525
    [Abstract] [Full Text] [Related]

  • 18. Interstitial keratitis secondary to severe hidradenitis suppurativa responding to adalimumab.
    Blanco R, González-Vela MC, González-López MA, Fernández-Llaca H, Cañal J, González-Gay MA.
    Cornea; 2012 Feb 15; 31(2):206; author reply 206. PubMed ID: 22146546
    [No Abstract] [Full Text] [Related]

  • 19. Bilateral Phlyctenular Keratoconjunctivitis in the Context of Hidradenitis Suppurativa: A Case Report and Literature Review.
    Gargallo-Benedicto A, Clemente-Tomás R, Pastor-Espuig M, Ballano-Ruiz A, Garzarán-Teijeiro A, Alias-Alegre E, Navarro-Casado MN.
    Ocul Immunol Inflamm; 2022 May 19; 30(4):992-994. PubMed ID: 33226311
    [Abstract] [Full Text] [Related]

  • 20. Peripheral ulcerative keratitis secondary to severe hidradenitis suppurativa.
    Dallalzadeh LO, Ang MJ, Beazer AP, Spencer DB, Afshari NA.
    Am J Ophthalmol Case Rep; 2022 Mar 19; 25():101403. PubMed ID: 35198822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.